(Q38025736)

27 August 2017

title

The therapeutic potential of 5-HT1A receptors: a patent review (English)

1 reference

27 August 2017

7

1 reference

27 August 2017

Enza Lacivita

1

0 references

author name string

Pantaleo Di Pilato

2

1 reference

27 August 2017

Paola De Giorgio

3

1 reference

27 August 2017

Nicola A Colabufo

4

1 reference

27 August 2017

Francesco Berardi

5

1 reference

27 August 2017

Roberto Perrone

6

1 reference

27 August 2017

language of work or name

English

0 references

publication date

13 July 2012

1 reference

Expert Opinion on Therapeutic Patents

27 August 2017

published in

1 reference

27 August 2017

volume

22

1 reference

27 August 2017

issue

8

1 reference

27 August 2017

page(s)

887-902

1 reference

Molecular, pharmacological and functional diversity of 5-HT receptors

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain — a combined in situ hybridisation/in vitro receptor autoradiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Serotonergic control of the hippocampus via local inhibitory interneurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Serotonergic modulation of cholinergic function in the central nervous system: cognitive implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Cell-specific physical and functional coupling of human 5-HT1A receptors to inhibitory G protein alpha-subunits and lack of coupling to Gs alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Distribution and neurochemical characterization of neurons expressing GIRK channels in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

5-HT1A receptor-regulated signal transduction pathways in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

The MAP Kinase Signaling Cascades: A System of Hundreds of Components Regulates a Diverse Array of Physiological Functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

5-HT1A receptor, an old target for new therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Buspirone: an update on a unique anxiolytic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Serotonin receptors: their key role in drugs to treat schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Actions of 5-hydroxytryptamine and 5-HT1A receptor ligands on rat dorso-lateral septal neurones in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Inhibition of hippocampal CA1 neurons by 5-hydroxytryptamine, derived from the dorsal raphe nucleus and the 5-hydroxytryptamine1A agonist SM-3997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

The recombinant 5-HT1A receptor: G protein coupling and signalling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Is there a role for 5-HT1A agonists in the treatment of depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Arylpiperazine derivatives acting at 5-HT(1A) receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Studies toward the discovery of the next generation of antidepressants. 3. Dual 5-HT1A and serotonin transporter affinity within a class of N-aryloxyethylindolylalkylamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Role of cortical and striatal 5-HT1A receptors in alleviating antipsychotic-induced extrapyramidal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

A role for the 5-HT(1A), 5-HT4 and 5-HT6 receptors in learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

The role of 5-HT(1A) receptors in learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

5-Hydroxytryptamine 1A receptor blockade facilitates aversive learning in mice: interactions with cholinergic and glutamatergic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Intraseptal injection of the 5-HT1A/5-HT7 agonist 8-OH-DPAT and working memory in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

5-hydroxytryptamine (5-HT, serotonin) and Parkinson's disease - opportunities for novel therapeutics to reduce the problems of levodopa therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Double-blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

A synaptic model of memory: long-term potentiation in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Neurotransmission--the link integrating Alzheimer research?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

The 5-HT1A antagonist, WAY 100 635, alleviates cognitive impairments induced by dizocilpine (MK-801) in monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Region- and phase-dependent effects of 5-HT(1A) and 5-HT(2C) receptor activation on adult neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Buspirone use for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Effects of buspirone in withdrawal from opiates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Synopsis of some recent tactical application of bioisosteres in drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

F15599, a highly selective post-synaptic 5-HT(1A) receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

Pardoprunox in early Parkinson's disease: results from 2 large, randomized double-blind trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.703654

10.1517/13543776.2012.703654

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference